Siemens Healthcare Announces Exclusive Partnership With Prowess Inc.

Concord, California (ots/PRNewswire) -

- Plans to Integrate Treatment Planning System with OncologySolutions Technology

Siemens Healthcare (www.usa.siemens.com/healthcare) announces anexclusive partnership with Prowess Inc. to develop advanced radiationoncology treatment planning software for integration into Siemens'linear accelerators. The combination of Prowess' unique treatmentplanning system with Siemens' leading oncology solutions technologywill help provide users with one of the most effective and reliableradiation therapy treatment solutions available in the market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

This agreement authorizes Siemens Healthcare to share the basicintellectual property of Prowess' patented Direct ApertureOptimization (DAO) planning software, allowing Siemens to incorporateProwess' software into the treatment planning tools for its linearaccelerators. This, in turn, will help users to dramatically reducethe number of segments, monitor units, and overall treatment times.

"This partnership with Prowess will provide us the ability todeliver a solution that helps clinical teams treat patients moreefficiently by reducing treatment times, dosage, and exposure ofhealthy tissues," said Holger Schmidt, Chief Executive Officer,Siemens Healthcare, Oncology Care Systems. "The open systemarchitecture will enable Siemens to offer users one of the broadestselections of treatment planning tools on the market."

"Working closely with Siemens, we are developing a joint solutionthat combines Siemens' innovative oncology therapy solutions with ourmarket-leading treatment planning system," said John Nguyen, CEO ofProwess. "We look forward to realizing the full potential of thispartnership and continuing to drive innovation in the oncologyfield."

The Prowess DAO-based Plan-to-Patient tool(i) for AdaptiveRadiation Therapy (ART) has been clinically evaluated and is plannedto be available in the spring of 2008. The tool works with Siemens'unique CTVision(TM) System, a SOMATOM(R) CT Sliding Gantry on railscombined with an ARTISTE(TM) or ONCOR(TM) Linear Accelerator. DAOenables users to make on-line plan corrections based on actualpre-treatment CT scans taken in the treatment room, while the patientis on the linear accelerator's treatment table.

Siemens is also working on the development of a highly-efficientsingle arc radiation treatment called Cone Beam Therapy (CBT)(i). Thecombination of CBT with DAO-based planning software will help improvetumor control for many disease sites, while sparing as much healthytissue as possible.

About Siemens Healthcare

Siemens Healthcare is one of the world's largest suppliers to thehealthcare industry. The company is a renowned medical solutionsprovider with core competence and innovative strength in diagnosticand therapeutic technologies as well as in knowledge engineering,including information technology and system integration. With itslaboratory diagnostics acquisitions, Siemens Healthcare will be thefirst fully integrated diagnostics company, bringing together imagingand lab diagnostics, therapy, and healthcare information technologysolutions, supplemented by consulting and support services. SiemensHealthcare delivers solutions across the entire continuum of care --from prevention and early detection, to diagnosis, therapy and care.The company employs more than 49,000 people worldwide and operates in130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcarereported sales of euro 9.85 billion (on a pro forma basis includingDade Behring roughly euro 11 billion), orders of euro 10.27 billion,and group profit of euro 1.32 billion. Further information can befound by visiting http://www.siemens.com/healthcare.

About Prowess Inc.

Prowess Inc. is an international radiation cancer treatmentplanning software developer based in Chico, California. Under thedirection and leadership of Mr. Nguyen, Prowess has continued to be apioneer in Windows-based treatment planning systems for brachytherapyand external beam therapy. Prowess' systems are noted for theiradvanced technology with an efficient and intuitive interface.

Prowess is a registered trademark of Prowess Inc. All othercompany and product names may be trademarks or registered trademarksof their respective companies. Further information can be found byvisiting http://www.prowess.com.

(i) The Plan to Patient tool and Cone Beam Therapy are works-in-progress, require FDA 510(k) pre-market clearance and are presently not available for commercial distribution. Web site: http://www.siemens.com/healthcare http://www.prowess.com

ots Originaltext: Siemens HealthcareIm Internet recherchierbar: http://www.presseportal.de

Contact:Tom Schaffner, +1-610-448-1477, thomas.schaffner@siemens.com; Photo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO

Siemens Healthcare

Zurück zur Übersiche Medizin-Nachrichten

Preisvergleich Medikamente
Medikament oder PZN:   
In Zusammenarbeit mit Medizinfuchs


Siemens Healthcare Announces Exclusive Partnership With Prowess Inc.